Logo image of ATHA

ATHIRA PHARMA INC (ATHA) Stock Analyst Ratings

USA - NASDAQ:ATHA - US04746L1044 - Common Stock

3.62 USD
-0.04 (-1.09%)
Last: 10/17/2025, 8:00:01 PM
Buy % Consensus

46

ChartMill assigns a Buy % Consensus number of 46% to ATHA. The Buy consensus is the weighted average rating of the current analysts ratings.

ATHA was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about ATHA.
In the previous month the buy percentage consensus was at a similar level.
ATHA was analyzed by 7 analysts. More opinions would make the average more meaningful.
ATHA Historical Analyst RatingsATHA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -60 -54 -48 -42 -36 -30 -24 -18 -12 -6 0 2 4 6 8 10
ATHA Current Analyst RatingATHA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-09-19 Mizuho Downgrade Outperform -> Neutral
2024-09-04 BTIG Downgrade Buy -> Neutral
2024-09-04 JMP Securities Downgrade Market Outperform -> Market Perform
2024-08-19 Rodman & Renshaw Initiate Buy
2024-06-20 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-05-16 JMP Securities Reiterate Market Outperform -> Market Outperform
2023-08-11 JMP Securities Maintains Outperform -> Outperform
2023-05-15 Mizuho Maintains Buy -> Buy
2023-03-30 BTIG Maintains Buy
2023-03-24 JMP Securities Reiterate Market Outperform
2022-07-07 Mizuho Initiate Buy
2022-06-23 JMP Securities Downgrade Market Outperform -> Market Perform
2022-06-23 Stifel Downgrade Buy -> Hold
2022-06-23 Jefferies Downgrade Buy -> Hold
2022-05-10 BTIG Initiate Buy
2022-04-21 Berenberg Initiate Buy
2021-12-15 Goldman Sachs Initiate Neutral